FDA Adverse Event Other Summary report: N

BRIDGEPOINT MEDICAL INC STINGRAY SYSTEM

MDR report key: 2582770 · Received May 18, 2012

Report

Report Number
3007210311-2012-00002
Event Type
Other
Date Received
May 18, 2012
Date of Event
April 20, 2012
Report Date
May 16, 2012
Manufacturer
BRIDGEPOINT MEDICAL INC.
Product Code
DQX
PMA / PMN Number
K10272
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

IN AN EFFORT TO UNDERSTAND AND ACCURATELY CHARACTERIZE BRIDGEPOINT MEDICAL DEVICE INVOLVEMENT, BRIDGEPOINT MEDICAL (B)(4) CONTACTED (B)(4) WHO HAD BEEN PRESENT AT THE CASE AND HAD FOLLOWED-UP WITH DR (B)(6) REGARDING THE PT'S STATUS, BOTH FELT THAT THE EVENT WAS DUE TO THROMBUS FORMATION IN THE GUIDE CATHETER.

Description of Event or Problem · 1

DURING A PROCEDURE ON A CTO LESION LOCATED IN THE MID-RCA IN WHICH GUIDE CATHETERS WERE POSITIONED IN THE OSTIUMS OF BOTH CORONARY TREES AND A STINGRAY SYS WAS POSITIONED IN THE DISTAL RCA, THE GUIDE CATHETER THAT WAS POSITIONED IN THE OSTIUM OF THE RCA UNEXPECTEDLY "FLIPPED" OUT OF THE OSTIUM. THE PT STARTED COMPLAINING OF SEVERE CHEST PAIN, ANGIOGRAPHY SHOWED THROMBUS IN THE RCA AND THE LAD. THE PT STARTED HAVING VENTRICULAR TACHYCARDIA WHICH REQUIRED CARDIOVERSION X 1 WHICH CONVERTED THE PT'S RHYTHM TO SINUS. PCI GEAR WAS REMOVED FROM THE PT AND THROMBECTOMY OF THE RCA AND LAD WAS PERFORMED WITH GOOD RESULTS, THE PT SHOWED NO ADVERSE EFFECTS FROM THE EPISODE. PRIOR TO THE EVENT, CONTRALATERAL INJECTIONS WERE BEING PERFORMED VIA THE GUIDE CATHETER POSITIONED IN THE OSTIUM OF THE LEFT CORONARY TREE, THE GUIDE CATHETER THAT WAS POSITIONED IN THE OSTIUM OF THE RIGHT CORONARY TREE HAD BEEN LEFT IN POSITION WITH MINIMAL FLUSHING PROCEDURES. IT WAS FELT THAT THROMBUS FORMED IN THE GUIDE CATHETER POSITIONED IN THE RIGHT CORONARY TREE AND WHEN IT UNEXPECTANTLY "FLIPPED" OUT OF THE OSTIUM A PORTION OF THE THROMBUS WAS LEFT IN THE PROXIMAL LUMEN OF THE RCA AND A PORTION OF THE THROMBUS WAS EXPORTED TO THE LEFT CORONARY TREE. F/U ON THE STATUS OF THE PT 5 DAYS POST ADVERSE EPISODE IT WAS NOTED THAT THE PT WAS DOING WELL WITH NO RESIDUAL EFFECTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 BRIDGEPOINT MEDICAL INC STINGRAY SYSTEM STINGRAY CATHETER/STINGRAY GUIDEWIRE DQX BRIDGEPOINT MEDICAL INC. M-1000/M-3004

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention